Optinose (OPTN): Rega marang dodolan
The price-to-sales ratio for OptiNose, Inc. (OPTN) highlights margin risks stemming from generic competition and marketing expenses, while 1.20 reflects the latest value of this metric. OptiNose, Inc. (OPTN) generates revenue through the sale of patented systems for nasopharyngeal therapy. Operations are strictly regulated by FDA standards, which limits the environmental footprint solely to the disposal of biomaterials.
Rincian metrik lan analitis perusahaan Optinose (OPTN)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Koefisien Total Utang marang Modal OptiNose, Inc.|OPTN - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal OptiNose Corp|OPTN - Utang perusahaan|Utang-utang marang nilai buku Optinose|OPTN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak OptiNose|Likuiditas darurat optinose.com
- indikator bathi lan kelipatan valuasi:
OPTN - Penghasilan resik|Penghasilan resik sing dikarepake OptiNose, Inc.|OPTN - Pangali P/E|Kapitalisasi marang proyeksi bathi OptiNose Inc|OPTN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Optinose|OPTN - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan OptiNose|OPTN - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan optinose.com|OPTN - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep OptiNose, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis fundamental perusahaan:OPTN - optinose.com
The P/S ratio determines the market value of a business relative to its annual sales volume, measuring the premium investors are willing to pay per unit of revenue. The capitalization-to-revenue trend reflects the efficiency of OptiNose, Inc. (OPTN) asset monetization amid aggressive marketing and generic pressure, where high costs to capture market share in nasal sprays may temporarily distort the company's fundamental valuation.
Pesaing OptiNose, Inc.
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue KVUE|Verona Pharma PLC (VRNA) - Rega marang dodolan|MENS - Rasio rega marang pendapatan|Rasio rega marang dodolan LGND|AMRX (Amneal Pharmaceuticals) - Kapitalisasi marang pendapatan|PRGO: Kapitalisasi marang volume dodolan|ALVO (Alvotech SA) - Multiplikator P/S|Liquidia Corp (LQDA) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|ANI Pharmaceuticals Corp - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan MannKind Corporation MNKD|amphastar.com (AMPH) - Rega marang dodolan|PCRX - Rasio rega marang pendapatan|Koefisien rega marang pendapatan ARS Pharmaceuticals Inc SPRY|TBPH: Multiplikator P/S|Rega marang dodolan Aquestive Corp (AQST)|Kapitalisasi marang pendapatan SCPH|TECX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TNXP|Koefisien rega marang pendapatan sxtchina.com|Rasio rega marang pendapatan Eupraxia Pharmaceuticals Inc. EPRX|BHST: Rasio kapitalisasi marang pendapatan|eXoZymes Inc - Multiplikator P/S|Oramed Pharmaceuticals (ORMP) - Kapitalisasi marang pendapatan|ENTX (enterabio.com) - Kapitalisasi marang pendapatan|HYFT - Koefisien rega marang pendapatan|Rasio rega marang pendapatan ABVC BioPharma Inc|Rega marang dodolan Cumberland Corp CPIX|Rasio rega marang pendapatan Quantum BioPharma Ltd (QNTM)|FGEN: Rasio rega marang dodolan|Telomir Pharmaceuticals, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan RANI (Rani Therapeutics Holdings)|SNYR - Rasio rega marang pendapatan|RLYB (Rallybio Corporation) - Rasio kapitalisasi marang pendapatan|lexariabioscience.com (LEXX) - Rasio rega marang pendapatan|Rasio rega marang dodolan PULM (pulmatrix.com)|PTHL (Pheton Holdings Limited) - Multiplikator P/S|APM: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S LYRA|Multiplikator P/S Impact BioMedical, Inc. (IBO)|Rasio rega marang pendapatan TNF Pharmaceuticals, Inc. TNFA|Rasio kapitalisasi pasar marang pendapatan YCBD|PRFX - Rasio rega marang pendapatan|Altamira Therapeutics (CYTO) - Kapitalisasi marang pendapatan|LIPO: Multiplikator P/S|Pieris Pharma (PIRS) - Multiplikator P/S|Kapitalisasi marang pendapatan PROC|PTPI: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Qilian International Holding (QLI)|SLRN - Rega marang dodolan|TFF Pharma - Kapitalisasi marang pendapatan
